ロード中...
Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla®, T-DM1) administration: a case report
BACKGROUND: Trastuzumab emtansine (Kadcyla®, T-DM1) is an antibody-drug conjugate used to treat HER2 (human epidermal growth factor receptor 2) overexpressing metastatic breast cancer. In this report, we present the first case of lacrimal drainage system stenosis identified after T-DM1 administratio...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683558/ https://ncbi.nlm.nih.gov/pubmed/31387552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5986-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|